Skip to main content
SpringerLink
Log in

Economic Implications of Sleep Disorders

  • Review Article
  • Economic Implications of Sleep Disorders
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Sleep disorders such as insomnia, obstructive sleep apnoea (OSA), excessive daytime sleepiness (EDS) and fatigue, sleep deprivation and restless legs syndrome (RLS) are increasingly seen in clinical practice. Sleep is considered vital for preserving daytime cognitive function and physiological well-being. Sleep insufficiency may have deleterious effects on work-life balance, overall health and safety. The consequential economic burden at both the individual and societal levels is significant. Moreover, sleep disorders are commonly associated with other major medical problems such as chronic pain, cardiovascular disease, mental illness, dementias, gastrointestinal disorders and diabetes mellitus. Thus, in order to properly care for patients presenting with sleep-related morbidity, and to reduce the consequential economic burden, accurate screening efforts and efficacious/cost-effective treatments need to be developed and employed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. American Academy of Sleep Medicine. International classification of sleep disorders, revised: diagnostic and coding manual. Chicago (IL): American Academy of Sleep Medicine, 2001 [online]. Available from URL: http://www.esst.org/adds/ICSD.pdf [Accessed 2010 Jul 29]

  2. Hossain JL, Shapiro CM. The prevalence, cost implications, and management of sleep disorders: an overview. Sleep Breath 2002; 6 (2): 85–102

    Article  PubMed  Google Scholar 

  3. National Sleep Foundation. 2005 Sleep in America poll: summary of findings. Washington, DC: National Sleep Foundation, 2005 Mar [online]. Available from URL: http://www.sleepfoundation.org/sites/default/files/2005_summary_of_findings.pdf [Accessed 2010 Jul 29]

  4. Dinges DF, Pack F, Williams K, et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4–5 hours per night. Sleep 1997; 20: 267–77

    PubMed  CAS  Google Scholar 

  5. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354 (9188): 1435–9

    Article  PubMed  CAS  Google Scholar 

  6. Spiegel K, Leproult R, L’hermite-Balériaux M, et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004; 89 (11): 5762–71

    Article  PubMed  CAS  Google Scholar 

  7. Spiegal K, Tasali E, Penev P, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141 (11): 846–50

    Google Scholar 

  8. Tochikubo O, Ikeda A, Miyajima E, et al. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318–24

    Article  PubMed  CAS  Google Scholar 

  9. Kato M, Phillips BG, Sigurdsson G, et al. Effects of sleep deprivation on neural circulatory control. Hypertension 2000; 35: 1173–5

    Article  PubMed  CAS  Google Scholar 

  10. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004; 43 (4): 678–83

    Article  PubMed  CAS  Google Scholar 

  11. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59 (2): 131–6

    Article  PubMed  Google Scholar 

  12. National Sleep Foundation. 2003 Sleep in America poll: executive summary. Washington, DC: National Sleep Foundation, 2003 Mar [online]. Available from URL: http://www.sleepfoundation.org/sites/default/files/2003SleepPollExecSumm.pdf [Accessed 2010 Jul 29]

  13. Foley DJ, Monjan A, Simonsick EM, et al. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6800 persons over three years. Sleep 1999; 22 Suppl. 2: S366–72

    Google Scholar 

  14. Morin CM, LeBlanc M, Daley M, et al. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006; 7: 123–30

    Article  PubMed  CAS  Google Scholar 

  15. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6 (2): 97–111

    Article  PubMed  Google Scholar 

  16. Doghramaji K. The epidemiology and diagnosis of insomnia. Am J Manag Care 2006; 12 (8 Suppl.): S214–20

    Google Scholar 

  17. Goldberg LD. Managing insomnia in an evolving marketplace. Am J Manag Care 2006; 12 (8 Suppl.): S212–3

    Google Scholar 

  18. National Sleep Foundation. 2007 Sleep in America poll: summary of findings. Washington, DC: National Sleep Foundation, 2007 [online]. Available from URL: http://www.sleepfoundation.org/sites/default/files/Summary_Of_Findings%20-%20FINAL.pdf [Accessed 2010 Jul 29]

  19. McCrae CS, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev 2001; 5: 47–61

    Article  PubMed  Google Scholar 

  20. Sateia MJ, Doghramji K, Hauri PJ, et al. Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep 2000; 23 (2): 243–309

    PubMed  CAS  Google Scholar 

  21. Skaer TL, Robison LM, Sclar DA, et al. Psychiatric comorbidity and pharmacological treatment patterns among patients presenting with insomnia: an assessment of office-based encounters in the USA in 1995 and 1996. Clin Drug Investig 1999; 18 (2): 161–7

    Article  Google Scholar 

  22. Skaer TL, Sclar DA, Robison LM. Complaint of insomnia in the United States 1995–1998: prevalence, psychiatric comorbidity, and pharmacologic treatment patterns. Prim Care Psych 2001; 7: 145–51

    Article  Google Scholar 

  23. McCall WV. A psychiatric perspective on insomnia. J Clin Psychiatry 2001; 62 Suppl. 10: 27–32

    Google Scholar 

  24. Ancoli-Isreal S. The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manag Care 2006; 12 (8 Suppl.): S221–9

    Google Scholar 

  25. Hatoum HT, Kong SX, Kania CM, et al. Insomnia, healthrelated quality of life and healthcare resource consumption: a study of managed-care organisation enrollees. Pharmacoeconomics 1998; 14 (6): 629–37

    Article  PubMed  CAS  Google Scholar 

  26. Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep 2006; 29 (3): 299–305

    PubMed  Google Scholar 

  27. Daley M, Morin CM, LeBlanc M, et al. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents. Sleep Med 2009; 10: 427–38

    Article  PubMed  CAS  Google Scholar 

  28. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. AmJ Psychiatry 1997; 154 (10): 1417–23

    CAS  Google Scholar 

  29. Silvertsen B, Overland S, Pallesen S, et al. Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res 2009; 18 (1): 122–8

    Google Scholar 

  30. Leger D, Guilleminault C, Bader G, et al. Medical and socioprofessional impact of insomnia. Sleep 2002; 25: 625–9

    PubMed  Google Scholar 

  31. Walsh JK, Engelhardt CL. The direct economic costs of insomniain theUnited States for 1995. Sleep 1999; 22 Suppl. 2: S386–93

    Google Scholar 

  32. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999; 22 Suppl. 2: S394–401

    Google Scholar 

  33. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia: an overview. Pharmacoeconomics 1996; 10 Suppl.1: 1–14

    Article  PubMed  Google Scholar 

  34. Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16: 873–97

    PubMed  CAS  Google Scholar 

  35. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007; 30: 263–73

    PubMed  Google Scholar 

  36. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999; 159: 502–7

    PubMed  CAS  Google Scholar 

  37. Weaver TE, Chasens ER. Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 2007; 11: 99–111

    Article  PubMed  Google Scholar 

  38. Norman D, Loredo JS. Obstructive sleep apnea in older adults. Clin Geriatr Med 2008; 24: 151–65

    Article  PubMed  Google Scholar 

  39. Nieto FJ, Young TB, Lind BK, et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study [published erratumappears in JAMA 2002; 288 (16): 1985]. JAMA 2000; 283 (14): 1829–36

    CAS  Google Scholar 

  40. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–84

    Article  PubMed  CAS  Google Scholar 

  41. Lavie Pk, Here P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479–82

    Article  PubMed  CAS  Google Scholar 

  42. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217–39

    Article  PubMed  Google Scholar 

  43. Banno K, Walld R, Kryger MH. Increasing obesity trends in patients with sleep-disordered breathing referred to a sleep disorders center. J Clin Sleep Med 2005; 1 (4): 364–6

    PubMed  Google Scholar 

  44. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006; 29: 109–17

    Article  PubMed  CAS  Google Scholar 

  45. Katzmarzyk PT, Mason C. Prevalence of class I, II, and III obesity in Canada. CMAJ 2006; 174: 156–7

    Article  PubMed  Google Scholar 

  46. Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in US adults, 1997–2003. Am J Prev Med 2006; 30: 371–7

    Article  PubMed  Google Scholar 

  47. Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med 2007; 8: 400–26

    Article  PubMed  Google Scholar 

  48. Otake K, Delaive K, Walld R, et al. Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoea. Thorax 2002; 57: 417–22

    Article  PubMed  CAS  Google Scholar 

  49. Tarasiuk A, Greenberg-Dotan S, Simon-Tuval T, et al. The effect of obstructive sleep apnea on morbidity and health care utilization of middle-aged and older adults. J Am Geriatr Soc 2008; 56: 247–54

    Article  PubMed  Google Scholar 

  50. Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol 2004; 29: 90–115

    Article  PubMed  Google Scholar 

  51. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97–106

    Article  PubMed  CAS  Google Scholar 

  52. Detournay B, Fagnani F, Phillippo M, et al. Obesity morbidity and health care costs in France: an analysis of the 1991–1992 Medical Care Household Survey. Int J Obes Relat Metab Disord 2000; 24: 151–5

    Article  PubMed  CAS  Google Scholar 

  53. Smith R, Ronald J, Delaive K, et al. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002; 121: 164–72

    Article  PubMed  Google Scholar 

  54. Santamaria J, Iranzo A, Ma Mantserrat J, et al. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev 2007; 11: 195–207

    Article  PubMed  Google Scholar 

  55. Tarasiuk A, Greenberg-Dotan S, Brin YS, et al. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients. Chest 2005; 128: 1310–4

    Article  PubMed  Google Scholar 

  56. Weaver TE, Grusteine RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 15: 173–8

    Article  Google Scholar 

  57. Simon-Tuval T, Reuveni H, Greenberg-Dontan S, et al. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep 2009; 32: 545–52

    PubMed  Google Scholar 

  58. Olsen S, Smith S, Oei T, et al. Health belief model predicts adherence to CPAP before experience with CPAP. Eur Respir J 2008; 32: 710–7

    Article  PubMed  CAS  Google Scholar 

  59. Reuveni H, Tarasiuk A, Wainstock T, et al. Awareness level of obstructive sleep apnea syndrome during routine unstructured interviews of a standardized patient by primary care physicians. Sleep 2004; 27: 1518–25

    PubMed  Google Scholar 

  60. Greenberg-Dotan S, Reuveni H, Simon-Tuval T, et al. Gender differences in morbidity and health care utilization among adult obstructive sleep apnea patients. Sleep 2007; 30: 1173–80

    PubMed  Google Scholar 

  61. Banno K, Manfreda J, Walld R, et al. Healthcare utilization in women with obstructive sleep apnea syndrome 2 years after diagnosis and treatment. Sleep 2006; 29: 1307–11

    PubMed  Google Scholar 

  62. Albarrak M, Banno K, Sabbagh AA, et al. Utilization of heathcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP. Sleep 2005; 28: 1306–11

    PubMed  Google Scholar 

  63. Banno K, Ramsey C, Walld R, et al. Expenditure on health care in obese women with and without sleep apnea. Sleep 2009; 32 (2): 247–52

    PubMed  Google Scholar 

  64. Pilcher JJ, Huffcutt AI. Effects of sleep deprivation on performance: a meta-analysis. Sleep 1996; 19: 318–26

    PubMed  CAS  Google Scholar 

  65. Berger LK, Cade BE, Ayas NT, et al. Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med 2005; 352: 125–34

    Article  Google Scholar 

  66. Boggild H, Knutsson A. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health 1999; 25: 85–99

    Article  PubMed  CAS  Google Scholar 

  67. Knutsson A. Health disorders of shift workers. Occup Med (Lond) 2003; 53 (2): 103–8

    Article  Google Scholar 

  68. Schwartz JRL, Roth T. Shift work sleep disorder: burden of illness and approaches to management. Drugs 2006; 66 (18): 2357–70

    Article  PubMed  CAS  Google Scholar 

  69. Folkard S, Tucker P. Shift work, safety and productivity. Occup Med 2003; 53: 95–101

    Article  Google Scholar 

  70. Drake CL, Roehrs T, Richardson G, et al. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep 2004; 27: 1453–62

    PubMed  Google Scholar 

  71. Puca FM, Perrucci S, Prudenzano MP, et al. Quality of life in shift work syndrome. Funct Neurol 1996; 5: 261–8

    Google Scholar 

  72. Dorrian J, Hussey F, Dawson D. Train driving efficiency and safety: examining the cost of fatigue. J Sleep Res 2007; 15: 1–11

    Article  Google Scholar 

  73. Smith JE, Tolson JM. Recognition, diagnosis, and treatment of restless legs syndrome. J Am Acad Nurse Pract 2008; 20: 396–401

    Article  PubMed  Google Scholar 

  74. Garcia-Borreguero D, Egatz R, WInkelmann J, et al. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2066; 10: 153–67

    Article  Google Scholar 

  75. Allen RP, Wahers A, Montplaisir J, et al. Restless legs syndrome prevelence and impact: REST general population study. Arch Intern Med 2005; 165: 1286–95

    Article  PubMed  Google Scholar 

  76. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164: 196–202

    Article  PubMed  Google Scholar 

  77. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160 (14): 2137–41

    Article  PubMed  CAS  Google Scholar 

  78. Spiegelhalder K, Hornyak M. Restless legs syndrome in older adults. Cliin Geriatr Med 2008; 24: 167–80

    Article  Google Scholar 

  79. Gomez-Esteban JC, Zarrantz JJ, Tijero R, et al. Restless legs syndrome in Parkinson’s disease. Mov Disord 2007; 22: 1912–6

    Article  PubMed  Google Scholar 

  80. Suzuki K, Ohida T, Sone T, et al. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems. Sleep 2003; 26: 672–7

    Google Scholar 

  81. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am J Kidney Dis 2005; 43: 763–71

    Article  Google Scholar 

  82. Chasens ER. Understanding sleep in persons with diabetes. Diabetes Educ 2007; 33 (3): 435–6, 438, 441

    Article  PubMed  Google Scholar 

  83. Merlino G, Fraticci L, Valente M, et al. Association of restless legs syndrome in type 2 diabetes: case-control study. Sleep 2007; 14: 534–9

    Google Scholar 

  84. Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004; 26 (6): 925–35

    Article  PubMed  Google Scholar 

  85. Kushiba C, Blaisdell B, Ferini-Strambi L. Burden of restless legs syndrome on health related quality of life. Qual Life Res 2007; 16: 617–24

    Article  Google Scholar 

  86. Reinhold T, MÜller-Riemenschneider F, Willich SN, et al. Economic and human costs of restless legs syndrome. Pharmacoeconomics 2009; 27 (4): 267–79

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to prepare this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Pharmacoeconomics and Pharmacoepidemiology Research Unit, College of Pharmacy, Washington State University, PO Box 646510, Pullman, Washington, 99164-6510, USA

    Tracy L. Skaer (Professor of Pharmacotherapy, Professor of Health Policy and Administration) & David A. Sclar

  2. Department of Pharmacotherapy, Washington State University, Pullman, Washington, USA

    Tracy L. Skaer (Professor of Pharmacotherapy, Professor of Health Policy and Administration) & David A. Sclar

  3. Department of Health Policy and Administration, Washington State University, Pullman, Washington, USA

    Tracy L. Skaer (Professor of Pharmacotherapy, Professor of Health Policy and Administration) & David A. Sclar

  4. Department of Statistics, Washington State University, Pullman, Washington, USA

    David A. Sclar

  5. Washington Institute for Mental Illness Research and Training, Spokane, Washington, USA

    David A. Sclar

Authors
  1. Tracy L. Skaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David A. Sclar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tracy L. Skaer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skaer, T.L., Sclar, D.A. Economic Implications of Sleep Disorders. Pharmacoeconomics 28, 1015–1023 (2010). https://doi.org/10.2165/11537390-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11537390-000000000-00000

Keywords

Search

Navigation